home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

82 rows where agency_id = "DEA" and posted_year = 2020 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: posted_month, comment_end_date, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 5

  • Rule 32
  • Supporting & Related Material 25
  • Proposed Rule 18
  • Notice 5
  • Other 2

posted_year 1

  • 2020 · 82 ✖

agency_id 1

  • DEA · 82 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
DEA-2020-0038-0003 DEA Schedules of Controlled Substances: Placement of Brorphine in Schedule I DEA-2020-0038 Three Factor Analysis for Temporary Control of Brorphine 11022020 clean_DOE-20-464 Other   2020-12-23T05:00:00Z 2020 12 2020-12-23T05:00:00Z   2020-12-23T19:27:46Z   0 0 09000064849c3ac5
DEA-2020-0038-0002 DEA Schedules of Controlled Substances: Placement of Brorphine in Schedule I DEA-2020-0038 Three Factor Analysis for Temporary Control of Brorphine Other   2020-12-23T00:00:00Z 2020 12     2020-12-23T19:21:40Z   0 1 09000064849c266d
DEA-2021-0001-0001 DEA Designation of APAA, PMK glycidate and PMK glycidic acid as List I chemicals DEA-2021-0001 Designation of 3,4-MDP-2-P methyl glycidate (PMK glycidate), 3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid), and alpha-phenylacetoacetamide (APAA) as List I Chemicals Proposed Rule   2020-12-21T05:00:00Z 2020 12 2020-12-21T05:00:00Z 2021-02-20T04:59:59Z 2021-02-25T13:50:56Z 2020-26813 0 0 09000064849aefe0
DEA-2020-0008-0255 DEA Controls To Enhance the Cultivation of Marihuana for Research in the United States DEA-2020-0008 Controls to Enhance the Cultivation of Marihuana for Research in the United States Rule   2020-12-18T05:00:00Z 2020 12 2020-12-18T05:00:00Z   2021-01-04T15:14:48Z 2020-27999 0 0 09000064849a768d
DEA-2021-0002-0001 DEA Schedules of Controlled Substances: Exempt Anabolic Steroid Products DEA-2021-0002 Schedules of Controlled Substances: Exempt Anabolic Steroid Products Rule   2020-12-16T05:00:00Z 2020 12 2020-12-16T05:00:00Z 2021-02-17T04:59:59Z 2021-01-06T18:55:28Z 2020-25288 0 0 09000064849a1ba4
DEA-2021-0004-0001 DEA Schedules of Controlled Substances: Removal of Samidorphan from Control DEA-2021-0004 Schedules of Controlled Substances: Removal of Samidorphan From Control Proposed Rule   2020-12-10T05:00:00Z 2020 12 2020-12-10T05:00:00Z 2021-01-12T04:59:59Z 2021-01-12T02:00:35Z 2020-26812 0 0 090000648499556e
DEA_FRDOC_0001-0330 DEA Recently Posted DEA Rules and Notices DEA_FRDOC_0001 Samidorphan_DEA_8F analysis_10-15-2020 Supporting & Related Material   2020-12-10T00:00:00Z 2020 12     2022-07-19T12:59:45Z   0 1 0900006484995f8f
DEA_FRDOC_0001-0329 DEA Recently Posted DEA Rules and Notices DEA_FRDOC_0001 HHS Samidorphan 2020 01-09 Supporting & Related Material   2020-12-10T00:00:00Z 2020 12     2022-07-19T13:00:03Z   0 1 0900006484995f8b
DEA-2020-0035-0001 DEA Partial Filling of Prescriptions for Schedule II Controlled Substances DEA-2020-0035 Partial Filling of Prescriptions for Schedule II Controlled Substances Proposed Rule   2020-12-04T05:00:00Z 2020 12 2020-12-04T05:00:00Z 2021-02-03T04:59:59Z 2021-02-03T02:00:28Z 2020-26291 0 0 0900006484985b6b
DEA-2020-0038-0001 DEA Schedules of Controlled Substances: Placement of Brorphine in Schedule I DEA-2020-0038 Schedules of Controlled Substances: Temporary Placement of Brorphine in Schedule I Proposed Rule   2020-12-03T05:00:00Z 2020 12 2020-12-03T05:00:00Z   2020-12-23T16:19:53Z 2020-26301 0 0 090000648498412a
DEA-2019-0008-0748 DEA Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2020 DEA-2019-0008 2020 Final APQ and AAN Notice   2020-12-01T05:00:00Z 2020 12 2020-12-01T05:00:00Z   2020-12-01T16:22:10Z   0 0 090000648497fdcc
DEA-2020-0026-0297 DEA Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021 DEA-2020-0026 2021 APQ and AAN (Established) Notice   2020-12-01T05:00:00Z 2020 12 2020-12-01T05:00:00Z   2020-12-01T16:38:41Z   0 0 090000648497fc36
DEA-2020-0002-0012 DEA Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I DEA-2020-0002 Schedules of Controlled Substances: Placement of Cyclopentyl Fentanyl, Isobutyryl Fentanyl, Para-chloroisobutyryl Fentanyl, Para-methoxybutyryl Fentanyl, and Valeryl Fentanyl in Schedule I Rule   2020-11-25T05:00:00Z 2020 11 2020-11-25T05:00:00Z   2020-12-03T14:36:18Z 2020-22757 0 0 09000064849757f9
DEA-2020-0031-0001 DEA Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment DEA-2020-0031 Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment Rule   2020-11-02T05:00:00Z 2020 11 2020-11-02T05:00:00Z 2021-01-05T04:59:59Z 2021-01-06T02:01:18Z 2020-23813 0 0 0900006484945a60
DEA-2021-0003-0001 DEA Suspicious Orders of Controlled Substances DEA-2021-0003 Suspicious Orders of Controlled Substances Proposed Rule   2020-11-02T05:00:00Z 2020 11 2020-11-02T05:00:00Z 2021-01-05T04:59:59Z 2021-02-25T16:35:27Z 2020-21302 0 0 0900006484945a99
DEA-2020-0032-0001 DEA Schedules of Controlled Substances: Placement of Oliceridine in Schedule II DEA-2020-0032 Schedules of Controlled Substances: Placement of Oliceridine in Schedule II Rule   2020-10-30T04:00:00Z 2020 10 2020-10-30T04:00:00Z 2020-12-01T04:59:59Z 2020-11-23T02:01:02Z 2020-22762 0 0 0900006484941681
DEA-2020-0033-0001 DEA Implementation of the Combat Methamphetamine Epidemic Act: Retail Sales; Transfers Following Importation or Exportation DEA-2020-0033 Implementation of the Combat Methamphetamine Epidemic Act: Retail Sales; Transfers Following Importation or Exportation Rule   2020-10-29T04:00:00Z 2020 10 2020-10-29T04:00:00Z   2020-11-13T20:35:20Z 2020-19311 0 0 090000648493e2ba
DEA-2020-0030-0002 DEA Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 DEA-2020-0030 Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act; Correction Rule   2020-10-22T04:00:00Z 2020 10 2020-10-22T04:00:00Z   2020-11-13T14:26:56Z 2020-22761 0 0 0900006484925d39
DEA-2020-0009-0005 DEA Schedules of Controlled Substances: Placement of 4,4'-DMAR in Schedule I DEA-2020-0009 4, 4'-DMAR HHS ltr and 8 Factor Analysis -2018 (1) Supporting & Related Material   2020-10-20T04:00:00Z 2020 10     2020-10-20T16:24:31Z   0 0 090000648491b75c
DEA-2020-0009-0004 DEA Schedules of Controlled Substances: Placement of 4,4'-DMAR in Schedule I DEA-2020-0009 4 4'-DMAR DEA 8 Factor Analysis 03-10-2020 Supporting & Related Material   2020-10-20T04:00:00Z 2020 10     2020-10-20T10:57:55Z   0 0 0900006484917a3d
DEA-2020-0028-0002 DEA Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV DEA-2020-0028 Remimazolam DEA 658 8-factor Supporting & Related Material   2020-10-08T04:00:00Z 2020 10     2020-10-08T17:05:13Z   0 0 09000064848ed460
DEA-2020-0028-0003 DEA Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV DEA-2020-0028 FINAL SIGNED ASH Response to DEA Remimazolam_04162020 Supporting & Related Material   2020-10-08T04:00:00Z 2020 10     2020-10-08T19:19:33Z   0 0 09000064848edc25
DEA-2020-0028-0001 DEA Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV DEA-2020-0028 Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV Rule   2020-10-06T04:00:00Z 2020 10 2020-10-06T04:00:00Z 2020-11-06T04:59:59Z 2020-11-07T02:00:38Z 2020-19313 0 0 09000064848dc25c
DEA-2020-0029-0001 DEA Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017 DEA-2020-0029 Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017 Proposed Rule   2020-10-05T04:00:00Z 2020 10 2020-10-05T04:00:00Z 2020-12-05T04:59:59Z 2020-12-06T02:00:55Z 2020-21675 0 0 09000064848ce421
DEA-2020-0034-0001 DEA Schedules of Controlled Substances: Placement of Crotonyl Fentanyl in Schedule I DEA-2020-0034 Schedules of Controlled Substances: Placement of Crotonyl Fentanyl in Schedule I Rule   2020-10-02T04:00:00Z 2020 10 2020-10-02T04:00:00Z   2020-12-08T16:43:11Z 2020-19305 0 0 09000064848b5019
DEA-2020-0030-0001 DEA Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 DEA-2020-0030 Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act Rule   2020-09-30T04:00:00Z 2020 9     2020-10-07T14:52:01Z 2020-21310 0 0 09000064848a25c4
DEA-2020-0027-0001 DEA Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration DEA-2020-0027 Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration Proposed Rule   2020-09-30T04:00:00Z 2020 9 2020-09-30T04:00:00Z 2020-12-01T04:59:59Z 2020-12-01T02:02:00Z 2020-19309 0 0 09000064848a25f0
DEA-2020-0026-0001 DEA Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021 DEA-2020-0026 Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021 Notice   2020-09-01T04:00:00Z 2020 9 2020-09-01T04:00:00Z 2020-10-02T03:59:59Z 2020-10-03T01:01:50Z   0 0 09000064848340df
DEA-2019-0008-0738 DEA Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2020 DEA-2019-0008 Proposed Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2020 Notice   2020-09-01T04:00:00Z 2020 9 2020-09-01T04:00:00Z 2020-10-02T03:59:59Z 2020-10-03T01:03:58Z   0 0 0900006484833ad7
DEA-2020-0025-0002 DEA Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I DEA-2020-0025 DEA 482 N-Ethylpentylone 8 Factor Supporting & Related Material   2020-08-28T04:00:00Z 2020 8     2020-08-28T14:32:25Z   0 0 0900006484824f5e
DEA-2020-0025-0003 DEA Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I DEA-2020-0025 FINAL SIGNED ASH Letter to DEA_8 Factor Analysis for N-ethylpentylone Supporting & Related Material   2020-08-28T04:00:00Z 2020 8     2020-08-28T14:32:37Z   0 0 0900006484824f5f
DEA-2020-0025-0001 DEA Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I DEA-2020-0025 Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I Proposed Rule   2020-08-27T04:00:00Z 2020 8 2020-08-27T04:00:00Z 2020-09-29T03:59:59Z 2020-09-28T01:01:08Z 2020-19007 0 0 0900006484823d52
DEA-2020-0024-0001 DEA Schedules of Controlled Substances: Extension of Temporary Placement of N-Ethylpentylone in Schedule I of the Controlled Substances Act DEA-2020-0024 Schedules of Controlled Substances: Extension of Temporary Placement of N-Ethylpentylone in Schedule I of the Controlled Substances Act Rule   2020-08-27T04:00:00Z 2020 8 2020-08-27T04:00:00Z   2020-08-27T16:50:39Z 2020-19011 0 0 0900006484823c45
DEA-2020-0023-0001 DEA Implementation of the Agricultural Improvement Act DEA-2020-0023 Implementation of the Agriculture Improvement Act of 2018 Rule   2020-08-21T04:00:00Z 2020 8 2020-08-21T04:00:00Z 2020-10-21T03:59:59Z 2020-10-22T01:02:32Z 2020-17356 0 0 09000064848168ac
DEA-2020-0017-0004 DEA Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I DEA-2020-0017 Three Factor Analysis for Temporary Control of Isotonitazene (DEA631) 07.21.20 Supporting & Related Material   2020-08-21T04:00:00Z 2020 8     2020-08-21T07:35:45Z   0 0 0900006484815d4e
DEA-2020-0017-0003 DEA Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I DEA-2020-0017 Schedules of Controlled Substances: Temporary Placement of Isotonitazene in Schedule I Rule   2020-08-20T04:00:00Z 2020 8 2020-08-20T04:00:00Z   2020-08-20T20:50:10Z 2020-17951 0 0 0900006484813e61
DEA-2020-0006-0007 DEA Schedules of Controlled Substances: Placement of Cenobamate in Schedule V DEA-2020-0006 Schedules of Controlled Substances: Placement of Cenobamate in Schedule V Rule   2020-08-20T04:00:00Z 2020 8 2020-08-20T04:00:00Z   2020-08-21T18:10:51Z 2020-17357 0 0 0900006484813f86
DEA-2020-0003-0007 DEA Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V DEA-2020-0003 Lasmiditan HHS ltr and 8 Factor Analysis Supporting & Related Material   2020-08-17T04:00:00Z 2020 8     2020-08-17T14:35:42Z   0 0 0900006484807b97
DEA-2020-0003-0008 DEA Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V DEA-2020-0003 8F Lasmiditan 06102020 Supporting & Related Material   2020-08-17T00:00:00Z 2020 8     2020-08-27T14:18:38Z   0 1 0900006484807b98
DEA-2020-0022-0001 DEA Reporting of Theft or Significant Loss of Controlled Substances DEA-2020-0022 Reporting of Theft or Significant Loss of Controlled Substances Proposed Rule   2020-07-29T04:00:00Z 2020 7 2020-07-29T04:00:00Z 2020-09-29T03:59:59Z 2020-09-28T01:01:01Z 2020-15635 0 0 09000064847b3625
DEA-2020-0007-0015 DEA Registration and Reregistration Fees: Controlled Substance and List I Chemical Registrants DEA-2020-0007 Registration and Reregistration Fees for Controlled Substance and List I Chemical Registrants Rule   2020-07-24T04:00:00Z 2020 7     2020-08-03T18:03:47Z 2020-16169 0 0 09000064847a240b
DEA-2020-0020-0001 DEA Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I DEA-2020-0020 Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I Proposed Rule   2020-07-13T04:00:00Z 2020 7 2020-07-13T04:00:00Z 2020-08-13T03:59:59Z 2020-08-13T01:01:57Z 2020-14901 0 0 0900006484745b40
DEA-2020-0021-0001 DEA Schedules of Controlled Substances: Extension of Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I of the Controlled Substances Act DEA-2020-0021 Schedules of Controlled Substances: Extension of Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I of the Controlled Substances Act Rule   2020-07-13T04:00:00Z 2020 7 2020-07-13T04:00:00Z   2020-07-17T14:08:49Z 2020-14902 0 0 0900006484745b77
DEA-2020-0017-0002 DEA Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I DEA-2020-0017 Three Factor Analysis for Temporary Control of Isotonitazene (DEA631) CLEAN 05052020 (1) Supporting & Related Material   2020-06-19T00:00:00Z 2020 6     2020-08-21T07:31:31Z   0 1 09000064846fae6c
DEA-2020-0017-0001 DEA Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I DEA-2020-0017 Schedules of Controlled Substances: Temporary Placement of Isotonitazene in Schedule I Proposed Rule   2020-06-18T04:00:00Z 2020 6 2020-06-18T04:00:00Z   2020-06-19T13:24:57Z 2020-12304 0 0 09000064846f8a81
DEA-2020-0018-0001 DEA Schedules of Controlled Substances: Exempt Anabolic Steroid Products DEA-2020-0018 Schedules of Controlled Substances: Exempt Anabolic Steroid Products Rule   2020-06-15T04:00:00Z 2020 6 2020-06-15T04:00:00Z 2020-08-15T03:59:59Z 2020-06-27T01:02:19Z 2020-11318 0 0 09000064846eebee
DEA-2020-0019-0001 DEA Listing of Ethylone in the Code of Federal Regulations and Assignment of an Administration Controlled Substances Code Number DEA-2020-0019 Listing of Ethylone in the Code of Federal Regulations and Assignment of an Administration Controlled Substances Code Number Rule   2020-06-08T04:00:00Z 2020 6 2020-06-08T04:00:00Z   2020-07-17T14:04:09Z 2020-10295 0 0 09000064846d38f0
DEA-2020-0016-0003 DEA Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I DEA-2020-0016 PMMA-HHS recommendation Supporting & Related Material   2020-05-26T04:00:00Z 2020 5     2020-05-26T16:55:22Z   0 0 09000064846ae01e
DEA-2020-0015-0005 DEA Schedules of Controlled Substances: Placement of Zipeprol in Schedule I DEA-2020-0015 Zipeprol 8 Factor HHS 05202013 Supporting & Related Material   2020-05-26T04:00:00Z 2020 5     2020-05-26T15:18:48Z   0 0 09000064846ad53d
DEA-2020-0015-0004 DEA Schedules of Controlled Substances: Placement of Zipeprol in Schedule I DEA-2020-0015 Zipeprol 8 Factor May 2020 Supporting & Related Material   2020-05-26T04:00:00Z 2020 5     2020-05-26T15:18:40Z   0 0 09000064846ad53b
DEA-2020-0016-0002 DEA Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I DEA-2020-0016 PMMA 8-factor review document Supporting & Related Material   2020-05-26T04:00:00Z 2020 5     2020-05-26T16:55:10Z   0 0 09000064846ae01d
DEA-2020-0015-0003 DEA Schedules of Controlled Substances: Placement of Zipeprol in Schedule I DEA-2020-0015 Zipeprol HHS Letter 05202013 Supporting & Related Material   2020-05-26T04:00:00Z 2020 5     2020-05-26T15:18:29Z   0 0 09000064846ad90a
DEA-2020-0016-0001 DEA Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I DEA-2020-0016 Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I Proposed Rule   2020-05-15T04:00:00Z 2020 5 2020-05-15T04:00:00Z 2020-06-16T03:59:59Z 2020-05-26T16:52:37Z 2020-09599 0 0 090000648460372c
DEA-2020-0015-0001 DEA Schedules of Controlled Substances: Placement of Zipeprol in Schedule I DEA-2020-0015 Schedules of Controlled Substances: Placement of Zipeprol in Schedule I Proposed Rule   2020-05-14T04:00:00Z 2020 5 2020-05-14T04:00:00Z 2020-07-14T03:59:59Z 2020-07-14T01:01:18Z 2020-09592 0 0 09000064845f501a
DEA-2010-0010-0102 DEA Electronic Prescriptions for Controlled Substances DEA-2010-0010 Electronic Prescriptions for Controlled Substances Rule   2020-04-21T04:00:00Z 2020 4 2020-04-21T04:00:00Z 2020-06-23T03:59:59Z 2020-06-24T01:00:39Z 2020-07085 0 0 09000064844bb877
DEA-2020-0013-0001 DEA Control of the Immediate Precursor Norfentanyl Used in the Illicit Manufacture of Fentanyl as a Schedule II Controlled Substance DEA-2020-0013 Control of the Immediate Precursor Norfentanyl Used in the Illicit Manufacture of Fentanyl as a Schedule II Controlled Substance Rule   2020-04-17T04:00:00Z 2020 4 2020-04-17T04:00:00Z   2020-04-21T15:50:59Z 2020-07381 0 0 09000064844b0e8b
DEA-2020-0012-0001 DEA Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals DEA-2020-0012 Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals Rule   2020-04-15T04:00:00Z 2020 4 2020-04-15T04:00:00Z   2020-04-21T15:43:10Z 2020-07064 0 0 09000064844a827d
DEA-2018-0001-0006 DEA Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I DEA-2018-0001 Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I; Correction Rule   2020-04-10T04:00:00Z 2020 4 2020-04-10T04:00:00Z   2020-04-13T17:09:35Z 2020-06984 0 0 090000648449963c
DEA-2019-0008-0731 DEA Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2020 DEA-2019-0008 Adjustments to Aggregate Production Quotas for Certain Schedule II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine and Pseudoephedrine for 2020, in Response to the Coronavirus Disease 2019 Public Health Emergency Notice   2020-04-10T04:00:00Z 2020 4 2020-04-10T04:00:00Z 2020-05-12T03:59:59Z 2020-05-12T01:01:25Z   0 0 090000648449a853
DEA-2020-0011-0001 DEA Schedules of Controlled Substances: Placement of Lemborexant in Schedule IV DEA-2020-0011 Schedules of Controlled Substances: Placement of Lemborexant in Schedule IV Rule   2020-04-07T04:00:00Z 2020 4 2020-04-07T04:00:00Z 2020-05-08T03:59:59Z 2020-05-08T01:02:18Z 2020-07089 0 0 090000648448e735
DEA-2020-0009-0001 DEA Schedules of Controlled Substances: Placement of 4,4'-DMAR in Schedule I DEA-2020-0009 Schedules of Controlled Substances: Placement of 4,4′-DMAR in Schedule I Proposed Rule   2020-04-07T04:00:00Z 2020 4 2020-04-07T04:00:00Z 2020-06-09T03:59:59Z 2020-10-19T14:31:29Z 2020-07095 0 0 090000648448e827
DEA-2020-0007-0005 DEA Registration and Reregistration Fees: Controlled Substance and List I Chemical Registrants DEA-2020-0007 Proposed Registration Fee Calculation Methodology Supporting & Related Material   2020-03-31T04:00:00Z 2020 3     2020-03-31T20:08:40Z   0 0 090000648447ceb7
DEA-2020-0010-0001 DEA Schedules of Controlled Substances: Placement of FUB-AMB in Schedule I DEA-2020-0010 Schedules of Controlled Substances: Placement of FUB-AMB in Schedule I Rule   2020-03-30T04:00:00Z 2020 3 2020-03-30T04:00:00Z   2020-04-21T15:36:15Z 2020-06176 0 0 09000064844770b6
DEA-2020-0008-0001 DEA Controls To Enhance the Cultivation of Marihuana for Research in the United States DEA-2020-0008 Controls To Enhance the Cultivation of Marihuana for Research in the United States Proposed Rule   2020-03-23T04:00:00Z 2020 3 2020-03-23T04:00:00Z 2020-05-23T03:59:59Z 2020-06-05T01:02:20Z 2020-05796 0 0 090000648445f2a9
DEA-2020-0007-0001 DEA Registration and Reregistration Fees: Controlled Substance and List I Chemical Registrants DEA-2020-0007 Registration and Reregistration Fees: Controlled Substance and List I Chemical Registrants Proposed Rule   2020-03-16T04:00:00Z 2020 3 2020-03-16T04:00:00Z 2020-05-16T03:59:59Z 2020-05-16T01:01:44Z 2020-05159 0 0 0900006484447dc2
DEA-2020-0006-0003 DEA Schedules of Controlled Substances: Placement of Cenobamate in Schedule V DEA-2020-0006 ASH Letter to Dhillon_01.15.2020 Supporting & Related Material   2020-03-10T04:00:00Z 2020 3     2020-03-10T18:47:09Z   0 0 0900006484426797
DEA-2020-0006-0002 DEA Schedules of Controlled Substances: Placement of Cenobamate in Schedule V DEA-2020-0006 8 Factor Cenobamate DEA March 2020 FINAL Supporting & Related Material   2020-03-10T04:00:00Z 2020 3     2020-03-11T12:53:52Z   0 0 0900006484420e81
DEA-2020-0006-0001 DEA Schedules of Controlled Substances: Placement of Cenobamate in Schedule V DEA-2020-0006 Schedules of Controlled Substances: Placement of Cenobamate in Schedule V Rule   2020-03-10T04:00:00Z 2020 3 2020-03-10T04:00:00Z 2020-04-10T03:59:59Z 2020-04-10T01:03:34Z 2020-04963 0 0 090000648441faec
DEA-2020-0006-0004 DEA Schedules of Controlled Substances: Placement of Cenobamate in Schedule V DEA-2020-0006 HHS Letter to Dhillon_12.3.19 Supporting & Related Material   2020-03-10T04:00:00Z 2020 3     2020-03-10T18:47:19Z   0 0 09000064844274be
DEA-2020-0005-0001 DEA Registration Requirements for Narcotic Treatment Programs with Mobile Components DEA-2020-0005 Registration Requirements for Narcotic Treatment Programs with Mobile Components Proposed Rule   2020-02-26T05:00:00Z 2020 2 2020-02-26T05:00:00Z 2020-04-28T03:59:59Z 2020-04-29T01:00:40Z 2020-03627 0 0 09000064843b4e82
DEA-2020-0002-0005 DEA Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I DEA-2020-0002 8-factor 5 Fentanyl Supporting & Related Material   2020-02-03T05:00:00Z 2020 2     2020-02-03T16:46:13Z   0 0 0900006484321f48
DEA-2020-0003-0001 DEA Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V DEA-2020-0003 Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V Rule   2020-01-31T05:00:00Z 2020 1 2020-01-31T05:00:00Z 2020-03-03T04:59:59Z 2021-05-25T15:40:37Z 2020-01957 0 0 0900006484316555
DEA-2020-0003-0009 DEA Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V DEA-2020-0003 DEA 8-factor review Lasmiditan 01232020 pdf Supporting & Related Material   2020-01-31T05:00:00Z 2020 1     2020-08-24T18:47:31Z   0 0 09000064843178f0
DEA-2020-0002-0004 DEA Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I DEA-2020-0002 Signed HHS Letter Supporting & Related Material   2020-01-31T05:00:00Z 2020 1     2020-01-31T15:21:22Z   0 0 090000648431707d
DEA-2020-0002-0003 DEA Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I DEA-2020-0002 8-factor 5 fentanyl Supporting & Related Material   2020-01-31T00:00:00Z 2020 1     2020-02-03T17:04:40Z   0 1 090000648431718e
DEA-2020-0002-0002 DEA Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I DEA-2020-0002 Schedules of Controlled Substances: Extension of Temporary Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I of the Controlled Substances Act Rule   2020-01-30T05:00:00Z 2020 1 2020-01-30T05:00:00Z   2020-01-31T14:33:57Z 2020-01683 0 0 090000648430a4e8
DEA-2020-0002-0001 DEA Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I DEA-2020-0002 Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I Proposed Rule   2020-01-30T05:00:00Z 2020 1 2020-01-30T05:00:00Z 2020-03-03T04:59:59Z 2020-03-03T02:02:48Z 2020-01681 0 0 090000648430aa75
DEA-2020-0001-0001 DEA Additions to Listing of Exempt Chemical Mixtures DEA-2020-0001 Additions to Listing of Exempt Chemical Mixtures Rule   2020-01-27T05:00:00Z 2020 1 2020-01-27T05:00:00Z 2020-02-27T04:59:59Z 2020-02-27T02:01:34Z 2020-00667 0 0 09000064842f597a
DEA-2016-0020-0015 DEA Schedules of Controlled Substances: Temporary Placement of six synthetic cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I DEA-2016-0020 Schedules of Controlled Substances: Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I Rule   2020-01-24T05:00:00Z 2020 1 2020-01-24T05:00:00Z   2020-02-03T18:59:03Z 2020-00665 0 0 09000064842e7a17
DEA-2019-0005-0007 DEA Schedules of Controlled Substances: Placement of Brexanolone in Schedule IV DEA-2019-0005 Schedules of Controlled Substances: Placement of Brexanolone in Schedule IV Rule   2020-01-24T05:00:00Z 2020 1 2020-01-24T05:00:00Z   2020-02-03T17:14:07Z 2020-00669 0 0 09000064842e7d87
DEA-2020-0004-0001 DEA Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control DEA-2020-0004 Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control Rule   2020-01-24T05:00:00Z 2020 1 2020-01-24T05:00:00Z   2020-02-03T18:20:33Z 2020-00664 0 0 09000064842e7d17
DEA-2019-0006-0005 DEA Schedules of Controlled Substances: Placement of Solriamfetol in Schedule IV DEA-2019-0006 Schedules of Controlled Substances: Placement of Solriamfetol in Schedule IV Rule   2020-01-07T05:00:00Z 2020 1 2020-01-07T05:00:00Z   2020-01-22T15:01:40Z 2019-27955 0 0 0900006484275aec

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 701.185ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API